Acellular dermal matrix (ADM) is a cell-free substance derived from biology. Initial applications of acellular dermal matrices included burn wound resurfacing, abdominal wall repair, tympanic membrane replacement, dural repairs, and gingival grafting. ADMs are now mostly used in plastic and breast surgery. Acellular dermal matrices are also used in the majority of reconstruction procedures, such as abdominal wall procedures like hernia repair, breast procedures like breast augmentation, orthopedic procedures, and the management of acute wounds like burns, traumatic wounds, cancer, and infections, as well as chronic wounds like diabetic foot ulcers, venous leg ulcers, pressure ulcers, and others.
Leading players are expected to launch a rising number of products during the projected period, supporting market expansion. The introduction and approval of technologically advanced acellular dermal matrices into the market is a major priority for the major players in the global acellular dermal matrices market, which is expected to drive market growth over the forecast period.
Over the projected period (2021-2028), the worldwide Acellular Dermal Matrices Market is expected to grow at a CAGR of 12.1%.
Prominent Companies in the Acellular Dermal Matrices Industry:
1. Integra LifeSciences Corporation
Integra LifeSciences Corporation is a multinational manufacturer of medical equipment. Its main office is in Princeton, New Jersey, where it was established in 1989. It operates in more than 130 countries. Positive clinical and financial outcomes on Integra® Bilayer Wound Matrix (IBWM) in challenging lower extremity repair were announced by Integra LifeSciences Holding Corporation, a world leader in medical technology, in May 2020. In Plastic and Reconstructive Surgery, the official publication of the American Society of Plastic Surgeons, Stephen J. Kovach, M.D., FACS, and John P. Fischer, M.D., MPH, FACS, from the University of Pennsylvania Health System, have just published the results of two retrospective examinations.
2. AbbVie Inc.
AbbVie Inc. is a pharmaceutical firm with its main office in North Chicago, Illinois, and was created in 2012. It runs operations in more than 70 nations. Good topline results from the phase 1/2 EPCORETM NHL-1 study of epcoritamab (DuoBody®-CD3xCD20) in patients with relapsed/refractory follicular lymphoma (FL) will be made public by AbbVie and Genmab in June 2023.
3. Johnson & Johnson
Johnson & Johnson is a division of Johnson & Johnson that produces and retails consumer healthcare goods. It is headquartered in New Jersey, USA, and was established in 1886. It is active in 60 nations.
4. Becton, Dickinson and Company
Becton, Dickinson and Company is a global American company that produces and markets reagents, instrument systems, and medical equipment. Its headquarters are in New Jersey, USA, where it was founded in 1897. It is present in more than 190 nations. The world's first commercial cell sorting instrument will be released by BD (Becton, Dickinson and Company) (NYSE: BDX) in May 2023. The instrument uses two ground-breaking technologies that enable researchers to see more specific information about cells that was previously hidden in conventional flow cytometry experiments.
5. Smith & Nephew Plc.
Smith & Nephew Plc. was founded in 1856 and headquartered in London, United Kingdom. It operates in more than 35 countries. In comparison to leading competitors, GRAFIXTM Membrane lowers the rate of diabetic foot ulcer recurrence by half, according to a new study by Smith+Nephew that will be published in March 2022.
6. LifeNet Health
LifeNet Health In October of 2019, LifeNet Health's Dermacell AWM®, the most advanced acellular dermal matrix (ADM) for wound therapy in the world, became the first human ADM to be made available in India. For the millions of people with chronic wounds in India, this introduction offers access to proven treatment.
7. Tissue Regenix
Tissue Regenix was founded in 2006 and headquartered in York, United Kingdom. It operates around the world. DermaPure® Meshed and VNEWTM, two line extensions to the business's BioSurgery division that utilise Tissue Regenix's patented decellularization ('dCELL®') Technology, will go on sale in September 2021, according to the regenerative medical technology company Tissue Regenix.
8. Zimmer Biomet Holdings, Inc
Zimmer Biomet Holdings, Inc is a publicly traded American firm with its headquarters in Indiana that manufactures medical equipment. In 1927, it was founded.It is present in more than 100 nations.
9. Stryker Corporation
Stryker Corporation is a worldwide corporation with its headquarters in the medical technology industry. In 1941, it was founded. It operates globally in more than 100 nations.
10. Baxter International Inc.
Baxter International Inc. is a 1931-founded global healthcare firm with its headquarters in Illinois, America. Over 100 nations throughout the world, including the United States, Canada, Mexico, Europe, Australia, Asia, Latin America, and the Middle East, are where it conducts business.
*Definition: The extracellular skin matrix is retained during the decellularization process that results in acellular dermal matrix (ADM), a soft connective tissue graft. After implantation, this structure serves as a scaffolding for donor-side cells, allowing eventual integration and revascularization.
